Northwest Cancer Specialists, P.C. Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2011
NCT00455052
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Northwest Cancer Specialists - Vancouver Cancer Center

Active Ingredients

Drugs in Phase 2 Trials (1)

tw1025 (1 trial)

Drugs in Phase 1 Trials (1)

xmt-1001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Fatigue (Phase 2)

Lung Neoplasms (Phase 1)

Small Cell Lung Carcinoma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2